Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration

Background: To determine whether it is possible to predict intravenous thrombolytic therapy (IVT) outcome after 3 months in acute ischemic stroke patients who are candidate to receive recombinant tissue plasminogen activator (rt-PA), before rt-PA administration based on their risk factors and some a...

Full description

Bibliographic Details
Main Authors: Masoud Mehrpour, Motahareh Afrakhteh, Seyedeh Fahimeh Shojaei, Ahmad Sohrabi, Rezan Ashayeri, Sara Esmaeili, Maryam Bahadori
Format: Article
Language:English
Published: Babol University of Medical Sciences 2019-09-01
Series:Caspian Journal of Internal Medicine
Subjects:
Online Access:http://caspjim.com/article-1-1610-en.html
id doaj-ab4d6eb4d4054980a13c0b5a40771419
record_format Article
spelling doaj-ab4d6eb4d4054980a13c0b5a407714192020-11-25T02:20:38ZengBabol University of Medical SciencesCaspian Journal of Internal Medicine2008-61642008-61722019-09-01104424430Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administrationMasoud Mehrpour0Motahareh Afrakhteh1Seyedeh Fahimeh Shojaei2Ahmad Sohrabi3Rezan Ashayeri4Sara Esmaeili5Maryam Bahadori6 Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, (IUMS), Tehran, Iran Department of Neurology, Firoozgar Hospital Iran, University of Medical Sciences (IUMS) Tehran, Iran Firoozgar Clinical Research and Development Center(FCRDC), Iran University of Medical Sciences(IUMS) , Tehran,Iran Infectious disease research center, Golestan University of Medical Sciences, Gorgan, Iran Department of Neurology, Firoozgar Hospital Iran, University of Medical Sciences (IUMS) Tehran, Iran Department of Neurology, Firoozgar Hospital Iran, University of Medical Sciences (IUMS) Tehran, Iran Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences(IUMS), Tehran, Iran Background: To determine whether it is possible to predict intravenous thrombolytic therapy (IVT) outcome after 3 months in acute ischemic stroke patients who are candidate to receive recombinant tissue plasminogen activator (rt-PA), before rt-PA administration based on their risk factors and some available laboratory results. Methods: We enrolled 118 ischemic stroke patients who were treated with standard dose of Alteplase in our hospital. Baseline characteristics, door-to-needle time (DTN), onset-to-treatment time (OTT), the National Institute Health Stroke Scale (NIHSS), systolic and diastolic blood pressure on admission, history of diabetes, hypertension, dyslipidemia, coronary artery disease (CAD), previous ischemic stroke, atrial fibrillation (AF), laboratory results were retrospectively collected. The modified Rankin Scale (mRS) was recorded after 3 months of admission and patients were divided into good (mRS£ 2) and poor (mRS>2) outcome groups. Chi-square test and t-test were used for categorical and continuous variables, respectively. Predictors for outcome after 3 months were studied by multivariable logistic regression. Results: Good outcome was seen in 60 (51%) patients and poor outcome was seen in 58 (49%) patients. Significant predictors for outcome at 3 months according to multivariable regression analysis were NIHSS score (odds ratio [OR], 0.61; 95% confidence interval [CI], 0.498-0.750; p<0.001), SBP (OR, 0.95; 95% CI, 0.925-0.991; P=0.01), AF (OR, 0.09; 95% CI, 0.013- 0.708; P=0.02), CAD (OR, 17.08; 95% CI, 0.013-0.708; p=0.003). Conclusion: Higher NIHSS score, higher SBP on admission, AF and history of CAD could be the independent predictors of outcome after IVT in acute ischemic stroke patients.http://caspjim.com/article-1-1610-en.htmlischemic strokethrombolytic therapyrt-pa
collection DOAJ
language English
format Article
sources DOAJ
author Masoud Mehrpour
Motahareh Afrakhteh
Seyedeh Fahimeh Shojaei
Ahmad Sohrabi
Rezan Ashayeri
Sara Esmaeili
Maryam Bahadori
spellingShingle Masoud Mehrpour
Motahareh Afrakhteh
Seyedeh Fahimeh Shojaei
Ahmad Sohrabi
Rezan Ashayeri
Sara Esmaeili
Maryam Bahadori
Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration
Caspian Journal of Internal Medicine
ischemic stroke
thrombolytic therapy
rt-pa
author_facet Masoud Mehrpour
Motahareh Afrakhteh
Seyedeh Fahimeh Shojaei
Ahmad Sohrabi
Rezan Ashayeri
Sara Esmaeili
Maryam Bahadori
author_sort Masoud Mehrpour
title Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration
title_short Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration
title_full Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration
title_fullStr Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration
title_full_unstemmed Factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-PA administration
title_sort factors predicting good outcome of intravenous thrombolysis in stroke patients before rt-pa administration
publisher Babol University of Medical Sciences
series Caspian Journal of Internal Medicine
issn 2008-6164
2008-6172
publishDate 2019-09-01
description Background: To determine whether it is possible to predict intravenous thrombolytic therapy (IVT) outcome after 3 months in acute ischemic stroke patients who are candidate to receive recombinant tissue plasminogen activator (rt-PA), before rt-PA administration based on their risk factors and some available laboratory results. Methods: We enrolled 118 ischemic stroke patients who were treated with standard dose of Alteplase in our hospital. Baseline characteristics, door-to-needle time (DTN), onset-to-treatment time (OTT), the National Institute Health Stroke Scale (NIHSS), systolic and diastolic blood pressure on admission, history of diabetes, hypertension, dyslipidemia, coronary artery disease (CAD), previous ischemic stroke, atrial fibrillation (AF), laboratory results were retrospectively collected. The modified Rankin Scale (mRS) was recorded after 3 months of admission and patients were divided into good (mRS£ 2) and poor (mRS>2) outcome groups. Chi-square test and t-test were used for categorical and continuous variables, respectively. Predictors for outcome after 3 months were studied by multivariable logistic regression. Results: Good outcome was seen in 60 (51%) patients and poor outcome was seen in 58 (49%) patients. Significant predictors for outcome at 3 months according to multivariable regression analysis were NIHSS score (odds ratio [OR], 0.61; 95% confidence interval [CI], 0.498-0.750; p<0.001), SBP (OR, 0.95; 95% CI, 0.925-0.991; P=0.01), AF (OR, 0.09; 95% CI, 0.013- 0.708; P=0.02), CAD (OR, 17.08; 95% CI, 0.013-0.708; p=0.003). Conclusion: Higher NIHSS score, higher SBP on admission, AF and history of CAD could be the independent predictors of outcome after IVT in acute ischemic stroke patients.
topic ischemic stroke
thrombolytic therapy
rt-pa
url http://caspjim.com/article-1-1610-en.html
work_keys_str_mv AT masoudmehrpour factorspredictinggoodoutcomeofintravenousthrombolysisinstrokepatientsbeforertpaadministration
AT motaharehafrakhteh factorspredictinggoodoutcomeofintravenousthrombolysisinstrokepatientsbeforertpaadministration
AT seyedehfahimehshojaei factorspredictinggoodoutcomeofintravenousthrombolysisinstrokepatientsbeforertpaadministration
AT ahmadsohrabi factorspredictinggoodoutcomeofintravenousthrombolysisinstrokepatientsbeforertpaadministration
AT rezanashayeri factorspredictinggoodoutcomeofintravenousthrombolysisinstrokepatientsbeforertpaadministration
AT saraesmaeili factorspredictinggoodoutcomeofintravenousthrombolysisinstrokepatientsbeforertpaadministration
AT maryambahadori factorspredictinggoodoutcomeofintravenousthrombolysisinstrokepatientsbeforertpaadministration
_version_ 1724871002640351232